## β₂-Adrenergic Receptor Desensitization: Acute Tachyphylaxis **Key Point:** Continuous or frequent exposure to β₂-agonists causes rapid loss of bronchodilator efficacy through **receptor phosphorylation and uncoupling** — a process distinct from receptor downregulation and occurring within days to weeks. ### Mechanism of Acute Tachyphylaxis **High-Yield:** β₂-adrenergic receptor desensitization occurs in two phases: #### Phase 1: Phosphorylation (Hours to Days) 1. **Continuous agonist stimulation** → sustained cAMP elevation 2. **PKA activation** → phosphorylates serine/threonine residues on the β₂-receptor intracellular loops 3. **GRK (G-protein receptor kinase) activation** → phosphorylates additional sites on the receptor tail 4. **β-arrestin binding** → sterically blocks G-protein coupling 5. **Result:** Receptor uncoupling from G~s~ protein → loss of cAMP generation despite agonist binding #### Phase 2: Internalization & Downregulation (Days to Weeks) - β-arrestin recruits clathrin → receptor endocytosis - Internalized receptors are degraded or recycled - Net loss of cell-surface receptor density ### Timeline in This Patient | Timeline | Mechanism | Clinical Finding | |----------|-----------|------------------| | **Days 1–3** | Phosphorylation, β-arrestin binding | Initial efficacy preserved | | **Days 3–7** | Receptor uncoupling, early internalization | Gradual loss of response | | **Week 2–3** | Receptor downregulation, reduced density | Marked tachyphylaxis; higher doses needed | **Clinical Pearl:** The patient's 3-week history of increasing salbutamol use with declining PEF is **classic tachyphylaxis** — the hallmark of acute β₂-agonist overuse. This is reversible with a 2-week drug holiday but is prevented by concurrent use of inhaled corticosteroids (ICS) or LABAs. ### Why LABA Addition Helps LABAs (e.g., salmeterol, formoterol): - Provide sustained, low-level β₂ stimulation (avoiding phasic peaks) - Allow receptor resensitization between doses - Reduce PKA-mediated phosphorylation - Are always paired with ICS in COPD/asthma (prevents tachyphylaxis) **Mnemonic:** **PAGED** — **P**hosphorylation, **A**rrestin binding, **G**-protein uncoupling, **E**ndocytosis, **D**ownregulation (the five steps of β-agonist tachyphylaxis). ### Molecular Pathway Diagram ```mermaid flowchart TD A[Continuous β₂-agonist exposure]:::action --> B[cAMP ↑↑]:::outcome B --> C[PKA activation]:::action C --> D[Receptor phosphorylation<br/>Ser/Thr residues]:::action D --> E[GRK activation]:::action E --> F[β-arrestin recruitment]:::action F --> G{Receptor fate}:::decision G -->|Short term| H[G-protein uncoupling<br/>Loss of cAMP response]:::outcome G -->|Long term| I[Clathrin-mediated<br/>endocytosis]:::action I --> J[Receptor degradation<br/>or recycling]:::outcome H --> K[Tachyphylaxis:<br/>Loss of bronchodilation]:::urgent J --> K ``` ### Distinction: Tachyphylaxis vs. Downregulation | Feature | Tachyphylaxis (Phosphorylation) | Downregulation | |---------|--------------------------------|----------------| | **Onset** | Hours to days | Days to weeks | | **Mechanism** | Uncoupling, not internalization | Reduced receptor density | | **Reversibility** | Rapid (hours–days washout) | Slow (1–2 weeks) | | **Prevention** | ICS, LABA, drug holidays | Avoid chronic agonist monotherapy | | **Receptor number** | Normal | Decreased | **Warning:** Exclusive reliance on short-acting β₂-agonists (SABAs) without ICS or LABA is a major cause of asthma/COPD exacerbations and death. This patient's regimen was inappropriate from the start. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.